These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31022805)

  • 1. Prognosis of Early-Onset
    Tábuas-Pereira M; Baldeiras I; Duro D; Santiago B; Ribeiro MH; Leitão MJ; Oliveira C; Santana I
    Geriatrics (Basel); 2016 Apr; 1(2):. PubMed ID: 31022805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological performance and conversion to Alzheimer's disease in early- compared to late-onset amnestic mild cognitive impairment: CREDOS study.
    Ye BS; Seo SW; Lee Y; Kim SY; Choi SH; Lee YM; Kim DH; Han HJ; Na DL; Kim EJ
    Dement Geriatr Cogn Disord; 2012; 34(3-4):156-66. PubMed ID: 23037957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of neuropsychological and FDG-PET findings between early- versus late-onset mild cognitive impairment: A five-year longitudinal study.
    Kim SH; Seo SW; Yoon DS; Chin J; Lee BH; Cheong HK; Han SH; Na DL
    Dement Geriatr Cogn Disord; 2010; 29(3):213-23. PubMed ID: 20332639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Impact of Age of Onset of Mild Cognitive Impairment on the Profile of Cognitive and Psychiatric Symptoms.
    Moustaka K; Nega C; Beratis IN
    Geriatrics (Basel); 2023 Sep; 8(5):. PubMed ID: 37887969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid.
    Rosenberg A; Solomon A; Jelic V; Hagman G; Bogdanovic N; Kivipelto M
    Alzheimers Res Ther; 2019 Dec; 11(1):99. PubMed ID: 31805990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Montreal Cognitive Assessment in Mild Cognitive Impairment: Relationship with Cerebrospinal Fluid Biomarkers and Conversion to Dementia.
    Bernardes C; Lima M; Duro D; Silva-Spínola A; Durães J; Tábuas-Pereira M; Baldeiras I; Freitas S; Santana I
    J Alzheimers Dis; 2023; 96(3):1173-1182. PubMed ID: 37927268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automatized FACEmemory® scoring is related to Alzheimer's disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort.
    Alegret M; Sotolongo-Grau O; de Antonio EE; Pérez-Cordón A; Orellana A; Espinosa A; Gil S; Jiménez D; Ortega G; Sanabria A; Roberto N; Hernández I; Rosende-Roca M; Tartari JP; Alarcon-Martin E; de Rojas I; Montrreal L; Morató X; Cano A; Rentz DM; Tárraga L; Ruiz A; Valero S; Marquié M; Boada M
    Alzheimers Res Ther; 2022 Mar; 14(1):43. PubMed ID: 35303916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Ritchie C; Smailagic N; Noel-Storr AH; Ukoumunne O; Ladds EC; Martin S
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010803. PubMed ID: 28328043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Factors for Conversion to Dementia in Individuals with Early-Onset Mild Cognitive Impairment.
    Baird K; Baillon S; Lau LSL; Storey M; Lindesay J; Velayudhan L
    Dement Geriatr Cogn Disord; 2021; 50(6):548-553. PubMed ID: 34937020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Utility of Cerebrospinal Fluid Aβ42 and Tau Measures in Diagnosing Mild Cognitive Impairment in Early Onset Dementia.
    Hosseini AA; Brown T; Mannino L; Gran B; Junaid K; Mukaetova-Ladinska EB
    J Alzheimers Dis; 2022; 87(2):771-780. PubMed ID: 35404281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing Alzheimer's disease: Which dementia screening test to use in elderly Puerto Ricans with mild cognitive impairment and early Alzheimer's disease?
    Rodríguez-Santiago MA; Wojna V; Miranda-Valentín E; Arnold S; Sepúlveda-Rivera V
    Alzheimers Dement (Amst); 2024; 16(1):e12554. PubMed ID: 38454965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choroid plexus volume as a novel candidate neuroimaging marker of the Alzheimer's continuum.
    Jiang J; Zhuo Z; Wang A; Li W; Jiang S; Duan Y; Ren Q; Zhao M; Wang L; Yang S; Awan MUN; Liu Y; Xu J
    Alzheimers Res Ther; 2024 Jul; 16(1):149. PubMed ID: 38961406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smell identification function in early-onset Alzheimer's disease and mild cognitive impairment.
    Velayudhan L; Wilson-Morkeh F; Penney E; Jesu AJM; Baillon S; Brugha T
    Int Psychogeriatr; 2019 Jul; 31(7):1065-1070. PubMed ID: 30318025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia.
    Buchhave P; Minthon L; Zetterberg H; Wallin AK; Blennow K; Hansson O
    Arch Gen Psychiatry; 2012 Jan; 69(1):98-106. PubMed ID: 22213792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cerebrospinal fluid biomarkers to predict conversion to dementia in patients with mild cognitive impairment: a clinical cohort study.
    Tondelli M; Bedin R; Chiari A; Molinari MA; Bonifacio G; Lelli N; Trenti T; Nichelli P
    Clin Chem Lab Med; 2015 Feb; 53(3):453-60. PubMed ID: 25274948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF p-tau/Aβ
    Santangelo R; Masserini F; Agosta F; Sala A; Caminiti SP; Cecchetti G; Caso F; Martinelli V; Pinto P; Passerini G; Perani D; Magnani G; Filippi M
    Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3152-3164. PubMed ID: 32415550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BIOFACE: A Prospective Study of Risk Factors, Cognition, and Biomarkers in a Cohort of Individuals with Early-Onset Mild Cognitive Impairment. Study Rationale and Research Protocols.
    Esteban de Antonio E; Pérez-Cordón A; Gil S; Orellana A; Cano A; Alegret M; Espinosa A; Alarcón-Martín E; Valero S; Martínez J; de Rojas I; Sotolongo-Grau Ó; Martín E; Vivas A; Gomez-Chiari M; Tejero MÁ; Bernuz M; Tárraga L; Ruiz A; Marquié M; Boada M;
    J Alzheimers Dis; 2021; 83(3):1233-1249. PubMed ID: 34420953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid biomarkers for neuropsychological symptoms in early stage of late-onset Alzheimer's disease.
    Kuo HC; Yen HC; Huang CC; Hsu WC; Wei HJ; Lin CL
    Int J Neurosci; 2015; 125(10):747-54. PubMed ID: 25290083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.